The American journal of psychiatry
-
Randomized Controlled Trial Comparative Study Clinical Trial
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
Current drug therapies for generalized anxiety disorder have limitations. In a controlled trial, the novel agent pregabalin was studied for the treatment of patients with generalized anxiety disorder. ⋯ These results indicate that pregabalin is an effective, rapidly acting, and safe treatment for generalized anxiety disorder. In short-term treatment, pregabalin does not appear to have the withdrawal symptoms associated with the benzodiazepines.